Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Regulus Therapeutics Inc
RGLSCurrent price
1.5 USD
-0.01 USD (-0.66%)
Last closed
1.56 USD
Company
www.regulusrx.com
ISIN
US75915K3095
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
96 234 872 USD
Yield for 12 month
+7.91 %
1Y
3Y
5Y
10Y
15Y
RGLS
Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California. Address: 4224 Campus Point Court, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.33 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-21 152 000 USD
Last Year
-122 000 USD
Current Quarter
–
Last Quarter
-89 000 USD
Key Figures RGLS
1 year
3 years
5 years
10 years
EBITDA
-44 258 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-42.39 %
PEG Ratio
-0.04
Return On Equity TTM
-72.36 %
Wall Street Target Price
10.33 USD
Revenue TTM
5 000 000 USD
Book Value
1.33 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
27677.8 %
Dividend Yield
–
Gross Profit TTM
-18 410 000 USD
Earnings per share
-1.2 USD
Diluted Eps TTM
-1.2 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RGLS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RGLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
29.06.2022
Dividend Date
04.10.2018
Stock Valuation RGLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.6573
Price Sales TTM
7.4299
Enterprise Value EBITDA
0.5691
Price Book MRQ
0.9802
Financials RGLS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RGLS
For 52 weeks
1.08 USD
3 USD
50 Day MA
1.55 USD
Shares Short Prior Month
2 848 644
200 Day MA
1.87 USD
Short Ratio
7.43
Shares Short
2 500 563
Short Percent
4.85 %
BeatStart